Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size for cohort studies in pharmacoepidemiology.

A D McMahon1, T M MacDonald

  • 1Medicines Monitoring Unit, Department of Clinical Pharmacology, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. alex@memo.dundee.ac.uk

Pharmacoepidemiology and Drug Safety
|April 10, 2004
PubMed
Summary

This paper explains how to calculate sample size for pharmacoepidemiology cohort studies with complex drug exposures. It focuses on determining the number of adverse events needed, not just subjects, for statistical significance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurodevelopment in small-for-gestational-age preterm infants: distinguishing the impact of birthweight and gestational age in a cohort study.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Assessing the risk of endogeneity bias in health and mortality inequalities research using composite measures of multiple deprivation which include health-related indicators: A case study using the Scottish Index of Multiple Deprivation and population health and mortality data.

Health & place·2023
Same author

Economic Evaluation of the Protecting Teeth @ 3 Randomized Controlled Trial.

JDR clinical and translational research·2022
Same author

Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2018
Same author

Is detecting oral cancer in general dental practices a realistic expectation? A population-based study using population linked data in Scotland.

British dental journal·2018
Same author

In response to: 'Thyroid hormone replacement - a counterblast to guidelines'.

The journal of the Royal College of Physicians of Edinburgh·2018

Area of Science:

  • Pharmacoepidemiology
  • Biostatistics
  • Drug Safety

Background:

  • Pharmacoepidemiologic cohort studies often involve complex drug exposure patterns, including periods of non-exposure.
  • Accurate sample size calculation is crucial for the validity of these studies.

Purpose of the Study:

  • To provide methods for calculating sample size in cohort studies with complex drug exposures.
  • To guide researchers in designing robust pharmacoepidemiologic investigations.

Main Methods:

  • Assumes adverse events follow Poisson distributions in two study groups.
  • Develops formulae for sample size calculation based on the number of events.
  • Highlights the importance of the ratio of person-years of exposure between groups.

Related Experiment Videos

Main Results:

  • Provides formulae for sample size determination in complex exposure scenarios.
  • Demonstrates that the ratio of person-years, not absolute exposure, is key for sample size.
  • Offers practical examples for application.

Conclusions:

  • The presented methods enable accurate sample size calculation for pharmacoepidemiology studies with intricate exposure profiles.
  • Understanding the role of person-years exposure is vital for efficient study design and resource allocation.